AI Science Tracker
EN

Dual-layer spectral detector computed tomography multiparameter machine learning model for prediction of lymph node metastases in esophageal squamous cell carcinoma.

Department of Computed Tomography and Magnetic Resonance, Xing Tai People's Hospital, 818 Xiangdu Road, Xing Tai, Hebei, 054000, China · 29 Jan 2026 · medicine

Discovery

Dual-layer spectral detector computed tomography multiparameter machine learning model for prediction of lymph node metastases in esophageal squamous cell carcinoma.

Source check: Source checked. Not independent scientific confirmation.

Finding: A multiparametric dual-layer spectral CT machine-learning model predicts lymph-node metastasis in esophageal squamous-cell carcinoma, with training- and test-cohort AUCs reported. Published in Cancer Imaging.

Technology: A multiparameter machine-learning model uses dual-layer spectral CT features to predict lymph-node metastasis in esophageal cancer.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
A multiparameter machine-learning model uses dual-layer spectral CT features to predict lymph-node metastasis in esophageal cancer.
Test and result
The full text describes the cohort or experimental system, comparison/reference, and internal/external or experimental validation used for the represented claim; no broader clinical benefit is inferred.
Limitation / still unknown
External replication and real-world or clinical benefit were not established by the reviewed study
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12924508/ · https://pubmed.ncbi.nlm.nih.gov/41612499/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.